Loading
A phase 1 trial of DNX-2401 run by Clinica Universidad de Navarra, Universidad de Navarra, completed.
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma is a phase 1 interventional study registered as NCT01956734 by Clinica Universidad de Navarra, Universidad de Navarra, with 31 participants enrolled, started 2013-09. Conditions recorded: Glioblastoma Multiforme and Recurrent Tumor. Interventions recorded: DNX2401 and Temozolomide.
Shares DNX-2401, DNAtrix, Glioma & glioblastoma and the tag pipeline.
Shares DNX-2401, DNAtrix, Glioma & glioblastoma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares DNX-2401, DNAtrix, Glioma & glioblastoma, Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/